GENERAL aspects of the diagnosis and management of differentiated thyroid carcinoma
(DTC) have been reviewed recently (1) and guidelines for management proposed (2). Yet …

Radioiodine is important in the diagnostic and therapeutic armamentarium of differentiated
thyroid cancer (DTC); however, many controversies persist. This article addresses some of …

Abstract purpose: To determine the long-term impact of medical and surgical treatment of
well differentiated papillary and follicular thyroid cancer. methods: Patients with papillary …

The first report of patients with thyroid cancer who were treated with radioiodine-131 (131-I)
was in 1946. 1 Since then, radioiodine (RAI) has been an important and wellaccepted …

Background It is not clear whether the administration of radioiodine provides any benefit to
patients with low-risk thyroid cancer after a complete surgical resection. The administration …

Introduction The purpose of the present guidelines on the radioiodine therapy (RAIT) of
differentiated thyroid cancer (DTC) formulated by the European Association of Nuclear …

Papillary and follicular thyroid cancer, together referred to as differentiated thyroid cancer
(DTC), is usually curable when discovered at an early stage. Its management, however, is …

Radioiodine plays an important role in the management of all papillary and follicular thyroid
cancer patients, except those with the best prognostic factors. External radiation is a …

Background: The American Thyroid Association guidelines recommend the routine use of
radioactive iodine for remnant ablation (RRA) in all T3 or greater primary tumors, and …

Objective To determine, based on published literature and expert clinical experience,
current indications for the post-surgical administration of a large radioiodine activity in …